Skip to main content

Shear Stress, Protein Kinases and Atherosclerosis

Buy Article:

$63.00 plus tax (Refund Policy)

Abstract:

Shear stress represents the frictional force that the flow of blood exerts at the endothelial surface of the vessel wall and plays a central role in cell function and structure via managing several processes and contributes to the progress of atherosclerosis. It is a fact that interaction of blood flow and the endothelial surface is the critical interface for shear stressdependent mechanotransduction. Vascular endothelial cells are equipped with numerous receptors in order to “sense” and react to mechanical forces elicited by shear stress. The intracellular signal transduction pathways and specifically the activation of protein kinases, is the second important molecular event underpinning cellular reactions to extracellular stimuli. MAPKs, comprising ERK1/2, JNKs/stress-activated protein kinases (SAPKs), and p38s, are serine/threonine protein kinases with a prominent role in cell differentiation, growth, and apoptosis, by modulating the activity of downstream target proteins and various transcription factors, hence gene expression programs. Shear stress (nonlaminar or disturbed blood flow) plays an important role in atherosclerosis, where flow conditions are characterized by low or oscillatory shear stress. Atherosclerosis is promoted by decreased shear stress, as it is associated with a suppression of functions taking place on the vascular wall, such as eNOs production and endothelial cell repair. In the presence of systemic risk factors, there is an increased tendency for atherosclerotic plaque formation, which, once formed, further disrupt flow and forward growth of the fibroinflammatory lipid plaque. Targeted inhibition of many kinase types and subtypes is an immense research field as this may lead to novel therapeutic approaches to prevent atherogenesis.

Keywords: Atheroprotective; MAPK pathway; NADPH oxidase; endothelial NO synthase; stress-activated protein kinases

Document Type: Research Article

DOI: http://dx.doi.org/10.2174/092986707780831087

Affiliations: Department of Biological Chemistry, Medical School, University of Athens, 75, M. Asias Street, 115 27 Athens, Greece.

Publication date: June 1, 2007

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
ben/cmc/2007/00000014/00000014/art00007
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more